EXTENDED EARLY BIRD RATE until 11th September 2023

BOPA Symposium Wales 2023: EARLY BIRD RATE extended until 11th September 2023

 

Oncology and haematology are ever-changing landscapes and this year we are looking to the future. The conference will include an exciting variety of specialist panel discussions, core clinical updates and specific research-focused streams. We are running a tiered system with sessions for everyone; from new to oncology pharmacists to advanced practitioners.

We recognise that NHS budgets are tighter than ever, so the committee have worked hard to give BOPA members a reduced conference fee of £260 (including VAT) if booked by the 11th September. As usual we have preferential rates at hotels nearby, but there are plenty of other options if you want to independently find accommodation.

To register, please CLICK HERE. Only PAID members will have access. For non-members link please contact [email protected]

For more information please click: https://www.bopa.org.uk/latest-symposium-2023/
For the draft agenda please click here

We look forward to seeing you all in Wales. Keep an eye out for monthly updates.

BOPA Symposium committee with Media1 Productions 

Latest News

By UK SACT Board Representatives - Joseph Williams and Netty Cracknell on 16th September 2025

Proposals for the reshaping of cancer services in England: funding for innovative cancer treatments

The Royal College of Radiologists (RCR) and the Society of Radiographers (SoR) have published a short document that expands on previous proposals for improving funding arrangements to enable equitable access…

Read article
By BOPA Exec Committee on 15th September 2025

Invitation to visit the BOPA stand at the BOPA Conference in Belfast

Hello All As an Executive Committee we are looking forward to meeting those of you who are signed up to come to the conference in Belfast next month. The BOPA…

Read article
By BOPA Research subcommittee on 14th September 2025

Survey: Fertility and the use of Immune Checkpoint Inhibitor Therapy (Survey from Royal Marsden Hospital)

Immune checkpoint inhibitors, such as atezolizumab, nivolumab and pembrolizumab have transformed the treatment landscape for many cancers. Cancers such as melanoma and Lynch-syndrome related tumours necessitating immune checkpoint inhibitors are…

Read article
By Clayton Wong on 8th September 2025

British Oncology Pharmacy Association (BOPA) invites you to Clinical Pharmacy Congress North 2025

British Oncology Pharmacy Association (BOPA) invites you to Clinical Pharmacy Congress North 21-22 November 2025 | Manchester Central Confirm your free delegate place *free places are only available for registered healthcare…

Read article